SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

24.25p
   
  • Change Today:
      0.25p
  • 52 Week High: 25.00p
  • 52 Week Low: 8.50p
  • Currency: UK Pounds
  • Shares Issued: 231.98m
  • Volume: 1,273,246
  • Market Cap: £56.25m
  • Beta: 0.02

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
98.51% above the market average98.51% above the market average98.51% above the market average98.51% above the market average98.51% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
75.13% above the market average75.13% above the market average75.13% above the market average75.13% above the market average75.13% above the market average
78.57% above the sector average78.57% above the sector average78.57% above the sector average78.57% above the sector average78.57% above the sector average
Price Book Ratio
96.11% below the market average96.11% below the market average96.11% below the market average96.11% below the market average96.11% below the market average
90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
91.14% above the market average91.14% above the market average91.14% above the market average91.14% above the market average91.14% above the market average
95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average95.92% above the sector average
Price Chg 3m
88.19% above the market average88.19% above the market average88.19% above the market average88.19% above the market average88.19% above the market average
83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
83.68% above the market average83.68% above the market average83.68% above the market average83.68% above the market average83.68% above the market average
91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average
Momentum 20
75.23% above the market average75.23% above the market average75.23% above the market average75.23% above the market average75.23% above the market average
86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
82% below the market average82% below the market average82% below the market average82% below the market average82% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
59.41% below the market average59.41% below the market average59.41% below the market average59.41% below the market average59.41% below the market average
8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
78% below the market average78% below the market average78% below the market average78% below the market average78% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average
Operating Profit Loss
62.21% below the market average62.21% below the market average62.21% below the market average62.21% below the market average62.21% below the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
76.25% below the market average76.25% below the market average76.25% below the market average76.25% below the market average76.25% below the market average
65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average
Cash
63.87% below the market average63.87% below the market average63.87% below the market average63.87% below the market average63.87% below the market average
70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 24.25p
Change Today 0.25p
% Change 1.04 %
52 Week High 25.00p
52 Week Low 8.50p
Volume 1,273,246
Shares Issued 231.98m
Market Cap £56.25m
Beta 0.02

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average70.8% below the market average
95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average
Price Trend
93.80% above the market average93.80% above the market average93.80% above the market average93.80% above the market average93.80% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
47.28% above the market average47.28% above the market average47.28% above the market average47.28% above the market average47.28% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average

SBTX Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
16:30 100,000 @ 24.25p
16:47 200,000 @ 0.24p
16:28 10,000 @ 24.14p
16:27 20,000 @ 24.43p
16:26 5,000 @ 24.13p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page